NovAliX (Minority Investment)
Funding Details
Awarder
RSS - feed.businesswire.com
Date Award
August 7, 2024
Vertical
Contract Research Organization (CRO)
Funding URL
View Funding Page
Company Info
Traction
NovAliX has achieved substantial revenue from its collaborations with biopharma customers and drug-discovery partners, predominantly in Europe, and is now expanding in the United States and Japan.
Organizations Involved
Max Planck Institute
Founders
Stephan Jenn
Market
Biopharma
Location
Strasbourg, Grand Est, France
Company Description

NovAliX is a company that aids managers, scientists, and project managers with drug discovery projects.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Contract Research Organization (CRO) DealsView Funding Announcement